Great analysis graeme_sl.Yes any partnerships from the big pharma like 'Johnson & Johnson' could take this company into the mainstream media coverage from the small cap space it's in now.
I am also glad to hear from the AGM info you mentioned that they are keeping costs under control. I've seen other small caps spend like crazy as soon as they are having early stage success with a new medical technology like OCC is having. If they could continue the progress with CelGro while keeping costs in check, future could look pretty bright as they continue to de-risk this treatment and win greater market share.
Ann: CelGro Accelerates Dental Implant Treatments, page-49
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
-0.015(3.23%) |
Mkt cap ! $94.30M | |||
| Open | High | Low | Value | Volume |
| 47.0¢ | 47.0¢ | 44.8¢ | $101.0K | 221.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6739 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 9799 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| OCC (ASX) Chart |